ROQUETTE has opened a new pharmaceutical Application Development Center at its site at Lestrem, France, expanding its services for excipients and active ingredients to the pharmaceutical industry.
 
The 800 m² lab offers compression, film coating or granulation, as well as the development of new galenic forms, one of the company’s latest innovations. ROQUETTE has developed an excipient for orodispersible tablets, a new form that melts directly in the mouth without the need for water, providing immediate action for the patient. The company will also provide expertise for pharmaceutical formulation.
 
ROQUETTE generates plant-based raw materials to develop and offer numerous galenic forms to patients: syrups, drinkable solutions, tablets, capsules, powders, etc. The excipients produced by ROQUETTE are designed to facilitate industrial production and cover a broad range of pharmaceutical applications.
 
Guillaume Fichet, director of the ROQUETTE Lestrem site, said, “The creation of this new Application Development Center on the Group’s largest site at Lestrem enables synergies with all of the Group’s research laboratories and production units at the site. Its ambition however is global. Located at the heart of Europe, this Application Development Center is in direct contact with the three other major regions of the Group (North America, Asia and India) and will serve our pharmaceuticals customers throughout the entire world.”